Austral Biologicals HPP-5013 - Rabbit anti-Helicobacter pylori Vac (toxin) antigen IgG fraction (polyclonal), 1 mg

Rabbit Anti-Helicobacter Pylori Vac (Toxin) Antigen, IgG Fraction, Polyclonal

1mg
$425.00
Skip to product information
Austral Biologicals HPP-5013 - Rabbit anti-Helicobacter pylori Vac (toxin) antigen IgG fraction (polyclonal), 1 mg

Rabbit Anti-Helicobacter Pylori Vac (Toxin) Antigen, IgG Fraction, Polyclonal

Catalog no. HPP-5013-9
$425.00
Size1mg

Rabbit polyclonal antibody raised against highly purified H. pylori Vac antigen. It has been purified using G protein.

  • Storage: Store at -20°C.
  • Stability: At least 1 year at -20°C.
  • Biological activity: This antibody has been used for Western Blot analysis at a 1/100-1/2000 dilution.
  • Formulation: Solution at 0.70 mg/mL in 0.1M Tris-HCl (pH 7.5)

Publications using Austral Biologicals HPP-5013-9

The following scientific publications report use of Austral Biologicals HPP-5013-9:

  1. Membrane lipid remodeling eradicates Helicobacter pylori by manipulating the cholesteryl 6'-acylglucoside biosynthesis. Ong et al., J Biomed Sci 31(1):44 (2024).
  2. Infection with a hypervirulent strain of Helicobacter pylori primes gastric cells toward intestinal transdifferentiation. Saberi et al., Microbial Pathogenesis 162:105353 (2022).
  3. Outer Membrane Vesicle Production by Helicobacter pylori Represents an Approach for the Delivery of Virulence Factors CagA, VacA and UreA into Human Gastric Adenocarcinoma (AGS) Cells. Chew et al., Int J Mol Sci 22(8):3942 (2021).
  4. Natural history of Helicobacter pylori VacA toxin in human gastric epithelium in vivo: vacuoles and beyond. Necchi et al., Sci Rep 7(1):14526 (2017).
  5. A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori. Wu et al., Medical Molecular Morphology 47(4):224-232 (2014).
  6. Helicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors. Prevete et al., International Journal of Immunopathology and Pharmacology 26(3):647-662 (2013).
  7. Ubiquitin-proteasome-rich cytoplasmic structures in neutrophils of patients with Shwachman-Diamond syndrome. Necchi et al., Haematologica 97(7):1057-1063 (2012).
  8. Proteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study. Necchi et al., PLoS One 6(6):e21317 (2011).
  9. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. Tan et al., PLoS Pathog 7(5):e1002050 (2011).
  10. Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. Ohno et al., J Infect Dis 203(5):726-735 (2011).
  11. In vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structure. Necchi et al., PLOS ONE 5(3):e9716 (2010).
  12. Characterization of the Vacuolating Cytotoxin in Helicobacter pylori Strains Isolated from Iran. Douraghi et al., Cell Journal (Yakhteh Medical Journal) 12(1):1-6 (2010).
  13. Stable accumulation of sigma54 in Helicobacter pylori requires the novel protein HP0958. Pereira et al., J Bacteriol 187(13):4463-4469 (2005).
  14. Role of activated protein C in Helicobacter pylori-associated gastritis. Oka et al., Infect Immun 68(5):2863-2869 (2000).

You may also like